Annovis Bio, Inc. (ANVS) Financials
ANVS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 22.0 million | 26.3 million |
| March 31, 2026 | 16.2 million | 13.1 million |
| Dec. 31, 2025 | 21.1 million | 4.2 million |
| Sept. 30, 2025 | 17.2 million | 4.0 million |
ANVS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -30.9 billion | 1.8 billion |
| March 31, 2026 | -9.0 million | 182823 |
| Dec. 31, 2025 | -8.9 million | 356524 |
| Sept. 30, 2025 | -3.5 million | 444647 |
ANVS Net Income
No data available :(
ANVS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 18.7 million | - | - |
| March 31, 2026 | 14.2 million | - | - |
| Dec. 31, 2025 | 19.5 million | - | - |
| Sept. 30, 2025 | 15.3 million | - | - |
ANVS Shares Outstanding
ANVS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 12.0 billion | 2.4 billion | - |
| March 31, 2026 | - | 16.7 billion | 1.3 billion | - |
| Dec. 31, 2025 | - | 8.8 million | 955151 | - |
| Sept. 30, 2025 | 5 | 6.3 million | 1.1 million | - |
ANVS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
ANVS
Price: $0.99
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 103127
Market Capitalization: 50.2 million